Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
According to a study published March 7 in the journal Cell Metabolism, a substance called fibroblast growth factor 21 (FGF21) protects mice from ethanol-induced loss of balance and right reflex.
Read Full NewsResearch reveals a significant skin-brain connection, linking inflammatory skin diseases to neurocognitive and emotional health, particularly in children with atopic dermatitis.
The REVISE trial, a phase 2 study evaluating GenSight Biologics’ lenadogene nolparvovec in patients with Leber hereditary optic neuropathy, is expected to begin in January 2026.
Intellia’s trial for nex-z in ATTR-CM remains under clinical hold.
Arai breaks down key recommendations from the 2025 AGA gastroparesis guidelines and what they mean for the field at large.
IMMpactful: Risankizumab Shows Greater Clinical Response to Deucravacitinib in Psoriasis
1.
The Higher the Disability Burden From Disease, the Higher the Suicide Risk
2.
WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research
3.
Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.
4.
No Cellphone, Brain Cancer Link; Testosterone Paradox; Breast Density and Cancer
5.
Children with cancer experience much less pain at home when using a pain monitoring app.
1.
Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers
2.
Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment
3.
Understanding Verrucous Carcinoma: Symptoms, Diagnosis, and Treatment Options
4.
Landmark Medical Oncology Trials Redefining Early Breast Cancer Management
5.
Colon cancer: Risk factors, warning signs and treatment options
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
2.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
3.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge